Tag: Parkinson’s disease
First Dual-Target Gene Therapy for Parkinson’s Disease Shows Promise in Early Trial
First-in-human trial of BBM-P002 dual-target gene therapy shows sustained 12-month motor improvements in Parkinson's disease patients with excellent safety profile.…
Orthostatic Hypotension in Parkinson’s Disease: New Clinical Practice Guidelines
New clinical guidelines address orthostatic hypotension, which affects up to 70% of Parkinson's patients. Evidence-based recommendations emphasize systematic screening and…
Gut microbiome screening could predict Parkinson’s disease risk years before symptoms emerge
New research published in Nature Medicine reveals that gut microbiome analysis could identify Parkinson's disease risk years before symptoms appear.…
Blocking Key Protein GPNMB Shows Promise in Halting Parkinson’s Disease Spread
Scientists have identified GPNMB, a protein that helps Parkinson's disease spread through the brain by creating a destructive cycle between…
Multi-arm platform trials could revolutionize neurological disease research
Platform trials could test 15-20 neurological treatments per decade compared to 3-5 using traditional methods. New Lancet commentary argues this…
New PET Tracer Successfully Detects Alpha-Synuclein in Living Brains for Parkinson’s Diagnosis
Revolutionary PET tracer [11C]MODAG-005 successfully detects alpha-synuclein protein aggregates in living brains, offering breakthrough potential for early Parkinson's disease diagnosis…
Vitamin D Directly Controls Dopamine Production in Human Brain Neurons, Studies Show
New research reveals vitamin D receptors are physically present in dopamine-producing brain neurons, where they directly control neurotransmitter synthesis and…
Vitamin D Directly Controls Dopamine Production in Human Brain Neurons According to Cui et al. Research
New research reveals vitamin D receptors are physically present in dopamine-producing brain neurons, where they directly control neurotransmitter synthesis and…